Allopurinol does not affect the anticonvulsant activity of carbamazepine and valproate in maximal electroshock-induced convulsions in mice.

Allopurinol, an inhibitor of xanthine oxidase, is indicated in the management of patients with elevated serum and urinary uric acid levels. It was also reported to be beneficial in patients with epilepsy when added to traditional antiepileptic drug. Here, we investigated the effect of allopurinol upon the electrical seizure threshold and its effect on the protective efficacy of common antiepileptic drugs, carbamazepine (CBZ) and valproate (VPA) against maximal electroshock (MES)-induced convulsions in mice. We found that allopurinol administered at doses of 5, 15 or 45 mg/kg, did not affect electrical seizure threshold. When administered acutely or for a prolonged period of time (5 times every 24 h), it did not affect anticonvulsant activity of CBZ and VPAin MES. Free plasma concentration of both anticonvulsants was not affected by allopurinol given at a dose of 45 mg/kg for 5 days. Thus, our results did not support suggestions that allopurinol can be beneficial as add-on drug in the management of epilepsy at least in patients treated with CBZ or VPA.

[1]  K. Borowicz,et al.  Polytherapy in epilepsy: the experimental evidence , 2002, Epilepsy Research.

[2]  H. Klandorf,et al.  Accelerated tissue aging and increased oxidative stress in broiler chickens fed allopurinol. , 2001, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.

[3]  M. Fabrizio,et al.  Pharmacology for renal calculi , 2000, Expert opinion on pharmacotherapy.

[4]  J R Pittman,et al.  Diagnosis and management of gout. , 1999, American family physician.

[5]  Y. Murashima,et al.  Antiepileptic effects of allopurinol on EL mice are associated with changes in SOD isoenzyme activities , 1998, Epilepsy Research.

[6]  G. Coppola,et al.  Double-blind, placebo-controlled, cross-over trial of allopurinol as add-on therapy in childhood refractory epilepsy , 1996, Brain and Development.

[7]  G. Zaccara,et al.  Allopurinol as Add‐on Therapy in Refractory Epilepsy: A Double‐Blind Placebo‐Controlled Randomized Study Italy, on his retirement. , 1994, Epilepsia.

[8]  Y. Wada,et al.  Anticonvulsant effect of allopurinol on hippocampal-kindled seizures , 1992, Pharmacology Biochemistry and Behavior.

[9]  K. Arimoto,et al.  Clinical Effects of Allopurinol on Intractable Epilepsy , 1991, Epilepsia.

[10]  W. Löscher,et al.  Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations , 1988, Epilepsy Research.

[11]  Josemir W Sander,et al.  Allopurinol as an add-on drug in the management of intractable epilepsy , 1988, Epilepsy Research.

[12]  Hopper Sa,et al.  The effect of allopurinol on oxygen-induced seizures in mice. , 1984 .

[13]  F. Wilcoxon,et al.  A simplified method of evaluating dose-effect experiments. , 1948, The Journal of pharmacology and experimental therapeutics.

[14]  E. Fernandes,et al.  Progress towards the discovery of xanthine oxidase inhibitors. , 2002, Current medicinal chemistry.

[15]  M. Iwaki,et al.  Drug interaction between phenytoin and allopurinol. , 1990, Journal of pharmacobio-dynamics.

[16]  Guzeva Vi,et al.  Allopurinol in the combined therapy of severe forms of epilepsy in children , 1988 .

[17]  I. B. Mikhailov,et al.  [Allopurinol in the combined therapy of severe forms of epilepsy in children]. , 1988, Zhurnal Nevropatologii I Psikhiatrii Imeni S S Korsakova.

[18]  S. F. Gottlieb,et al.  The effect of allopurinol on oxygen-induced seizures in mice. , 1984, Aviation Space and Environmental Medicine.

[19]  I. B. Mikhailov,et al.  [Pharmaco-dynamic mechanisms for reducing the activity of an epileptogenic focus with allopurinol]. , 1983, Zhurnal Nevropatologii I Psikhiatrii Imeni S S Korsakova.

[20]  Gusel' Va,et al.  [Pharmaco-dynamic mechanisms for reducing the activity of an epileptogenic focus with allopurinol]. , 1983 .

[21]  J. Boissier,et al.  Une nouvelle méthode simple pour explorer l’action «tranquillisante»: le test de la cheminée , 1960 .